At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 23 enrolled
Drug / intervention
VGH-BPH1 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Traditional Chinese Medicine VGH-BPH1 on Patients With Benign Prostatic Hyperplasia: A Double-blinded Randomized Placebo-controlled Cross-over Study
In Brief
A Phase 2 clinical trial evaluating VGH-BPH1 and Placebo (Corn starch pill manufactured to mimic VGH-BPH1) for Benign Prostatic Hyperplasia. Completed, enrolled 23 participants across 1 site.
Detailed Summary
This randomized, double-blinded, placebo-controlled, crossover clinical trial aims to investigate the effect of VGH-BPH1, a scientific Chinese medicine powder prescription, on patients with benign prostatic hyperplasia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBenign Prostatic Hyperplasia
CountriesTaiwan
Collaborators--
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
First PostedFeb 2019
Enrollment StartMar 2019
Primary CompletionJan 2020
TodayJul 2026
First PostedFeb 4, 2019
Enrollment StartMar 6, 2019
Primary CompletionJan 2, 2020
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 7.4 years ago
Interventions
VGH-BPH1drug
A scientific Chinese granule powder
Placebo (Corn starch pill manufactured to mimic VGH-BPH1)drug
Corn starch pill manufactured to mimic VGH-BPH1